228 related articles for article (PubMed ID: 35653914)
1. Understanding brain function in vascular cognitive impairment and dementia with EEG and MEG: A systematic review.
Torres-Simón L; Doval S; Nebreda A; Llinas SJ; Marsh EB; Maestú F
Neuroimage Clin; 2022; 35():103040. PubMed ID: 35653914
[TBL] [Abstract][Full Text] [Related]
2. Vascular Cognitive Impairment (VCI).
Rundek T; Tolea M; Ariko T; Fagerli EA; Camargo CJ
Neurotherapeutics; 2022 Jan; 19(1):68-88. PubMed ID: 34939171
[TBL] [Abstract][Full Text] [Related]
3. Neuropsychological assessment and cerebral vascular disease: the new standards.
Godefroy O; ; Leclercq C; Bugnicourt JM; Roussel M; Moroni C; Quaglino V; Beaunieux H; Taillia H; Nédélec-Ciceri C; Bonnin C; Thomas-Anterion C; Varvat J; Aboulafia-Brakha T; Assal F
Rev Neurol (Paris); 2013 Oct; 169(10):779-85. PubMed ID: 23999023
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and management of vascular cognitive impairment and dementia.
Erkinjuntti T
J Neural Transm Suppl; 2002; (63):91-109. PubMed ID: 12597611
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor involvement in vascular cognitive impairment and vascular dementia pathogenesis and treatment.
Nguyen DH; Cunningham JT; Sumien N
Geroscience; 2021 Feb; 43(1):159-166. PubMed ID: 32902819
[TBL] [Abstract][Full Text] [Related]
6. The concept of vascular cognitive impairment.
Erkinjuntti T; Gauthier S
Front Neurol Neurosci; 2009; 24():79-85. PubMed ID: 19182465
[TBL] [Abstract][Full Text] [Related]
7. EEG measures for clinical research in major vascular cognitive impairment: recommendations by an expert panel.
Babiloni C; Arakaki X; Bonanni L; Bujan A; Carrillo MC; Del Percio C; Edelmayer RM; Egan G; Elahh FM; Evans A; Ferri R; Frisoni GB; Güntekin B; Hainsworth A; Hampel H; Jelic V; Jeong J; Kim DK; Kramberger M; Kumar S; Lizio R; Nobili F; Noce G; Puce A; Ritter P; Smit DJA; Soricelli A; Teipel S; Tucci F; Sachdev P; Valdes-Sosa M; Valdes-Sosa P; Vergallo A; Yener G
Neurobiol Aging; 2021 Jul; 103():78-97. PubMed ID: 33845399
[TBL] [Abstract][Full Text] [Related]
8. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association.
Gorelick PB; Scuteri A; Black SE; Decarli C; Greenberg SM; Iadecola C; Launer LJ; Laurent S; Lopez OL; Nyenhuis D; Petersen RC; Schneider JA; Tzourio C; Arnett DK; Bennett DA; Chui HC; Higashida RT; Lindquist R; Nilsson PM; Roman GC; Sellke FW; Seshadri S;
Stroke; 2011 Sep; 42(9):2672-713. PubMed ID: 21778438
[TBL] [Abstract][Full Text] [Related]
9. Clinical presentations and epidemiology of vascular dementia.
Smith EE
Clin Sci (Lond); 2017 Jun; 131(11):1059-1068. PubMed ID: 28515342
[TBL] [Abstract][Full Text] [Related]
10. Vascular cognitive disorder: a new diagnostic category updating vascular cognitive impairment and vascular dementia.
Román GC; Sachdev P; Royall DR; Bullock RA; Orgogozo JM; López-Pousa S; Arizaga R; Wallin A
J Neurol Sci; 2004 Nov; 226(1-2):81-7. PubMed ID: 15537526
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein ɛ4 is Associated with Dementia and Cognitive Impairment Predominantly Due to Alzheimer's Disease and Not with Vascular Cognitive Impairment: A Singapore-Based Cohort.
Chai YL; Yeo HK; Wang J; Hilal S; Ikram MK; Venketasubramanian N; Wong BS; Chen CL
J Alzheimers Dis; 2016; 51(4):1111-8. PubMed ID: 26923016
[TBL] [Abstract][Full Text] [Related]
12. Pathology and pathophysiology of vascular cognitive impairment. A critical update.
Jellinger KA
Panminerva Med; 2004 Dec; 46(4):217-26. PubMed ID: 15876978
[TBL] [Abstract][Full Text] [Related]
13. Plasma osteopontin as a biomarker of Alzheimer's disease and vascular cognitive impairment.
Chai YL; Chong JR; Raquib AR; Xu X; Hilal S; Venketasubramanian N; Tan BY; Kumar AP; Sethi G; Chen CP; Lai MKP
Sci Rep; 2021 Feb; 11(1):4010. PubMed ID: 33597603
[TBL] [Abstract][Full Text] [Related]
14. Vascular cognitive impairment.
Farooq MU; Gorelick PB
Curr Atheroscler Rep; 2013 Jun; 15(6):330. PubMed ID: 23612956
[TBL] [Abstract][Full Text] [Related]
15. The assessment of cognitive and behavioural disturbances in vascular cognitive impairment (VCI) - recommendations of an expert working group.
Calabrese P; Sitek EJ; Korczyn AD; Dong Y; Manso-Calderón R; Sierra-Beltrán M; Skrzypkowska A; Stefanova E
Neurol Neurochir Pol; 2021; 55(4):333-345. PubMed ID: 34096014
[TBL] [Abstract][Full Text] [Related]
16. Vascular cognitive impairment: dementia biology and translational animal models.
Barone FC; Rosenbaum DM; Zhou J; Crystal H
Curr Opin Investig Drugs; 2009 Jul; 10(7):624-37. PubMed ID: 19579168
[TBL] [Abstract][Full Text] [Related]
17. Language Impairment in Vascular Dementia: A Clinical Review.
Macoir J
J Geriatr Psychiatry Neurol; 2024 Mar; 37(2):87-95. PubMed ID: 37551643
[TBL] [Abstract][Full Text] [Related]
18. Neuropsychiatric manifestations in vascular cognitive impairment patients with and without dementia.
Chiu PY; Liu CH; Tsai CH
Acta Neurol Taiwan; 2007 Jun; 16(2):86-91. PubMed ID: 17685132
[TBL] [Abstract][Full Text] [Related]
19. Current perspectives on prevention of vascular cognitive impairment and promotion of vascular brain health.
Kalaria RN; Akinyemi RO; Paddick SM; Ihara M
Expert Rev Neurother; 2024; 24(1):25-44. PubMed ID: 37916306
[TBL] [Abstract][Full Text] [Related]
20. Disease progression in vascular cognitive impairment: cognitive, functional and behavioural outcomes in the Consortium to Investigate Vascular Impairment of Cognition (CIVIC) cohort study.
Rockwood K; Moorhouse PK; Song X; MacKnight C; Gauthier S; Kertesz A; Montgomery P; Black S; Hogan DB; Guzman A; Bouchard R; Feldman H;
J Neurol Sci; 2007 Jan; 252(2):106-12. PubMed ID: 17189642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
